MID-DAY Market Update – 04 June 2025
By CapitalKeeper | Mid Day | Indian Equities | Market Moves That Matter
Indian Indices Stable Amid Global Caution; Pharma Sector Gears for Outperformance
Indian stock markets are witnessing a steady yet cautiously optimistic session on 04 June 2025, with key indices trading slightly higher by mid-day. Despite global uncertainties, market sentiment remains balanced. Pharma stocks are emerging as potential outperformers and could lead gains over the next 5 sessions until 11 June.
📊 Index Snapshot (Mid-Day Levels)
| Index | Open | Current | Change |
|---|---|---|---|
| Nifty 50 | 24,560 | 24,606 | 🔼 +46 pts |
| Sensex | 80,777 | 80,958 | 🔼 +181 pts |
| Bank Nifty | 55,650 | 55,654 | 🔼 +4 pts |
| Fin Nifty | 26,254 | 26,285 | 🔼 +31 pts |
The market breadth has improved slightly, with FMCG, Pharma, and Auto stocks seeing selective buying interest.
🌐 Global Cues – Mixed But Not Risk-Off Yet
- Wall Street Overnight: Nasdaq gained modestly on AI stock momentum; Dow remained flat.
- Asia: Nikkei and Kospi trading cautiously ahead of U.S. employment data.
- Crude Oil: Stable at $72.85 per barrel – OPEC+ signals production support.
- Dollar Index: Hovers around 105.10; Rupee trades near 83.25.
🔍 Sectoral Trends – Pharma Shows Signs of Early Breakout
🔼 Gaining Sectors:
- Pharma: Building strength quietly; stocks like Cipla, Lupin, Sun Pharma advancing with improving volumes and RSI > 55 on hourly charts.
- FMCG: Defensive buying continues, led by Tata Consumer and ITC.
- Auto: Mild positive bias as M&M and Tata Motors hold firm.
🔻 Lagging Sectors:
- IT: Facing mild resistance on global tech volatility.
- Metals: Profit booking in JSW Steel and Tata Steel; China macro data still weak.
🧪 Note: “Pharma sector might start to outperform in the next 5 working days till 11th June.”
📉 Technical Outlook
Nifty 50
- Support: 24,520 / 24,460
- Resistance: 24,670 / 24,730
- RSI: 53 – neutral to positive
- MACD: Flatline; awaiting directional bias
Bank Nifty
- Support: 55,400 / 55,100
- Resistance: 55,900
- RSI: 50 – neutral
- Price Action: Holding above 20-EMA on hourly, but weak momentum
🔥 5 Active Intraday Stocks – Mid-Day Picks
- Cipla (₹1,475.90)
- Strong volume breakout from consolidation
- Target: ₹1,495 | SL: ₹1,622
- Tata Consumer (₹1,126.40)
- Sustaining momentum post-gap up
- Target: ₹1,145 | SL: ₹1,113
- M&M (₹3,051.50)
- Stable structure; bullish flag forming
- Target: ₹3,090 | SL: ₹3,020
- Axis Bank (₹1,173.10)
- Tight range; breakout expected above ₹1,168
- Target: ₹1,185 | SL: ₹1,155
- Lupin (₹1,938.20)
- RSI <40 on hourly; bullish crossover seen
- Target: ₹2,090 | SL: ₹1,910
📊 FII & DII Activity (Morning Data)
- FIIs: Mild selling seen in index futures; cautious positioning continues
- DIIs: Net buyers in cash market; inflows into Pharma, Auto, and FMCG
- Overall institutional flow remains range-bound ahead of U.S. job data and RBI policy meet
🔚 Conclusion
The Indian stock market is holding steady in mid-day trading with selective sector participation. Technical charts are hinting at a consolidation phase, with Pharma likely to emerge as a breakout leader.
With macro events lined up globally, traders should watch key support levels while staying aligned with stock-specific momentum plays.
📈 Stay tuned with CapitalKeeper.in for live market updates, daily trade ideas, and swing strategies built on technical analysis.
🔔 Stay tuned to CapitalKeeper.in for:
- Opening Bell & Closing Reports
- Futures Stock Picks & RSI/MACD-Based Trades
- Weekly Sectoral Outlook
- Beginner-Friendly Educational Blogs
Avoid chasing momentum blindly; stick to technically strong setups
📌 For more real-time updates, trade setups, and investment insights — follow us on [Telegram] and subscribe to our newsletter!
📌 Disclaimer
The content provided on CapitalKeeper.in is for informational and educational purposes only and does not constitute investment, trading, or financial advice. While we strive to present accurate and up-to-date market data and analysis, we make no warranties or representations regarding the completeness, reliability, or accuracy of the information.
Stock market investments are subject to market risks, and readers/investors are advised to conduct their own due diligence or consult a SEBI-registered financial advisor before making any investment decisions. CapitalKeeper and its authors are not liable for any loss or damage, direct or indirect, arising from the use of this information.
All views and opinions expressed are personal and do not reflect the official policy or position of any agency or organization. Past performance is not indicative of future results.
By using this website, you agree to the terms of this disclaimer.